Cite
HARVARD Citation
Djimde, A. et al. (n.d.). OC 8721 WANECAM II – a clinical trial programme to assess safety, efficacy and transmission-blocking properties of a new antimalarial KAF156 (ganaplacide) in uncomplicated malaria in west and central africa. BMJ global health. pp. A17-A18. [Online].